[On the differential antithrombotic and thrombolytic therapy of priapism].
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D001778:Blood Coagulation Disorders; D004322:Drainage; D007172:Erectile Dysfunction / Q000209:etiology; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000150:complications; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000098:blood supply*; D010653:Phenylbutazone / Q000009:adverse effects; D011317:Priapism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D013300:Streptokinase / Q000008:administration & dosage; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D014546:Urinary Catheterization
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D010653:Phenylbutazone
Zur antithrombotischen-thrombolytischen Differentialtherapie des Priapismus.